New cancer immunotherapy drugs rapidly reach patients after approval
The majority of patients eligible for cancer immunotherapy drugs known as checkpoint inhibitors received treatment within a few months of FDA approval, according to a new Yale-led study. The finding suggests that cancer immunotherapies are adopted at a much quicker pace than is typical for newly approved medical treatments, the researchers said. However, patients receiving the therapies are older than those in the clinical trials used to evaluate them, pointing to a disconnect between research and practice that should be addressed, they noted.
Affordable Care Act lowered uninsured rate for cancer survivors
The percentage of cancer survivors without health insurance decreased substantially after implementation of the Affordable Care Act (ACA), reports a study in the March issue of Medical Care, published by Wolters Kluwer. Cancer survivors eligible for Medicaid expansion under the ACA had the greatest decrease in uninsured rate, according to the new research by Amy J. Davidoff, PhD, of Yale School of Public Health, New Haven, Conn., and colleagues. They write, "ACA implementation was associated with large coverage gains in targeted expansion groups, including cancer survivors, but additional progress is needed."Source: Eurekaalert
Solomon Center to Host Conference on Policy, Politics and Law of Cancer
The Solomon Center for Health Law and Policy at Yale Law School—in collaboration with Smilow Cancer Hospital and Yale Cancer Center—will host a major interdisciplinary conference addressing topics at the cutting edge of cancer policy. Titled “The Policy, Politics and Law of Cancer,” the conference will be held in New Haven on February 8-9th, 2018. his event brings together leading figures in the worlds of cancer care, research, regulation, and policymaking to assess the current state of cancer policy and discuss ways in which law can influence its development. No event of comparable scale has been held in Connecticut—and the conference breaks new ground substantively, both within Connecticut and beyond, according to the organizers.Source: Yale Law
The National Cancer Moonshot Summit: what are the key priorities?
The National Cancer Moonshot Summit is being held today in the US, and in this blog, I asked two of our Editors-in-Chief what they think are the main priorities in achieving the Moonshot goals. Barbara Burtness - We find ourselves at a time in cancer research when the unprecedented wealth of genomic data, novel insights into the role of the immune system in controlling cancer, and a rich pipeline of new systemic therapies are leading to dramatic improvements in survival even for patients with advanced disease.Source: BioMed Central
Yale Cancer Center Heads to Capitol Hill for AACR's Hill Day
Yale Cancer Center's Drs. David Stern, Roy Herbst, and Howard Hochster are on Capitol Hill today for American Association for Cancer Research (AACR)'s Hill Day. During Hill Day the team is visiting with Connecticut's representatives and staff to talk about the importance of funding for cancer research and patient programs and to provide an update on the impact Yale Cancer Center and Smilow Cancer Hospital are having in the fight against cancer.
Yale clinician meets with vice president’s staff on cancer “moonshot”
Patricia M. LoRusso, D.O., professor of medicine (medical oncology) and associate director of Innovative Medicine at Yale Cancer Center, was among a group of 15 top cancer researchers and physician-scientists who met in Washington with aides to Vice President Joe Biden on Jan. 8 to discuss his “moonshot” program to advance cancer treatment.
Cancer and Tobacco Experts Not Fired Up about E-Cigarettes for Quitting Smoking
Despite overwhelming evidence linking cigarettes to serious diseases like cancer, leading experts in cancer research and tobacco policy are not ready to recommend electronic nicotine delivery systems (ENDS), like e-cigarettes, as a safe way to quit smoking. E-cigarettes remain unregulated by the FDA, pose health hazards, and should not be marketed to people younger than 18, according to a national policy statement published Jan. 8 in two prominent cancer journals.
An ‘Epic’ pushback as U.S. prepares for new era of empowering patient health data
Epic, the largest electronic health record company in the U.S., launched an effort last week to persuade hospital CEOs across the country to fight recent efforts by the federal government to ensure that patients can easily access their electronic health data.Source: STAT
Not so conscientious objection: When can doctors refuse to treat?
In overturning the Trump administration’s attempt to expand the so-called conscience rule for health care workers this week, a federal judge has brought renewed attention to a long-simmering debate in medicine over when doctors can decline to provide treatment to patients without abdicating their professional responsibilities.Source: STAT
Landmark Conference Sept. 26-27 at Yale Law School: "The Affordable Care Act at 10: History, Legacy, Challenges"
This unprecedented gathering will reflect on the policy, legal, and political advances and challenges that a decade of the Affordable Care Act has brought us. We will gather the leading scholars and some of the most important players involved in the Affordable Care Act's passage and implementation, including former White House Chief of Staff Rahm Emanuel, former HHS Secretary Kathleen Sebelius, former U.S. Solicitors General Donald Verrilli and Paul Clement, and many others.
YSPH Collaborating with China to Develop New Medical Payment Models
Improving China’s medical payment models was the topic of discussion when Yale School of Public Health Dean Sten H. Vermund traveled to Beijing in January 2019 to meet with officials from China’s National Health Commission as part of the country’s ongoing healthcare reform efforts.
Zack Cooper Receives Carnegie Fellowship to Support Research on Drug Pricing
Health economist Zack Cooper, associate professor at the Yale School of Public Health and in the Department of Economics, is one of 32 recipients of this year’s Andrew Carnegie Fellowship, awarded by the Carnegie Corporation of New York.